Although there has been great progress in CRC treatments, including surgery, chemotherapy, radiotherapy, anti-EGFR therapy, anti-VEGF, and immunotherapy, patients with CRC exhibit poor survival times (2). The gene discussed is EGFR; the disease is colorectal carcinoma.